{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:49:53Z","timestamp":1786985393868,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bjid.2020.04.015","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:48:03Z","timestamp":1590194883000},"page":"191-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost minimization analysis of an in-house molecular test for cytomegalovirus in relation to a commercial molecular system"],"prefix":"10.1016","volume":"24","author":[{"given":"C\u00e1ssia F.B.","family":"Caurio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odelta S.","family":"Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Kist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izadora C.S.","family":"Vasconcellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francieli P.","family":"Rozales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel","family":"Reck-Kortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane F.","family":"Dalla Lana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Alegretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi\u00e1como B.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-5395","authenticated-orcid":false,"given":"Alessandro C.","family":"Pasqualotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2020.04.015_bib0005","unstructured":"CDC. Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the Nati. Available from: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf [accessed 02.11.19]."},{"key":"10.1016\/j.bjid.2020.04.015_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age","volume":"52","author":"Enders","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12877","article-title":"Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the organ transplant infection prevention and detection (OTIP) study: a multi-year. Multi-center prospective cohort study","volume":"20","author":"Avery","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bjid.2020.04.015_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12732","article-title":"Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting","volume":"19","author":"Hakimi","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bjid.2020.04.015_bib0025","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1128\/jcm.28.9.2069-2075.1990","article-title":"Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection","volume":"28","author":"Boland","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0030","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1128\/jcm.30.11.2822-2825.1992","article-title":"Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes","volume":"30","author":"Erice","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bmt.1701525","article-title":"The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation","volume":"23","author":"Humar","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bjid.2020.04.015_bib0040","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0041-1345(99)00654-5","article-title":"Cytomegalovirus antigenemia and renal function post-kidney-transplantation","volume":"31","author":"Schr\u00f6eder","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bjid.2020.04.015_bib0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.bjid.2020.04.015_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3343\/alm.2015.35.1.99","article-title":"Comparison of quantitation of cytomegalovirus DNA by real-time pcr in whole blood with the cytomegalovirus antigenemia assay","volume":"35","author":"Kwon","year":"2015","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.bjid.2020.04.015_bib0055","first-page":"39","article-title":"Clinical applications of molecular biology for infectious diseases","volume":"27","author":"Speers","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.bjid.2020.04.015_bib0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/JCM.01287-11","article-title":"Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis","volume":"50","author":"Hayden","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0065","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-6143.2008.02513.x","article-title":"Interlaboratory comparison of cytomegalovirus viral load assays","volume":"9","author":"Pang","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bjid.2020.04.015_bib0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biologicals.2016.04.005","article-title":"A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology","volume":"44","author":"Fryer","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.bjid.2020.04.015_bib0075","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1128\/JCM.02005-13","article-title":"Comparison of six real-time pcr assays for qualitative detection of cytomegalovirus in clinical specimens","volume":"51","author":"Binnicker","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jcv.2012.08.017","article-title":"Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay","volume":"55","author":"Furione","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jviromet.2012.04.010","article-title":"Quantitation of human cytomegalovirus DNA in plasma using an affordable in-house qPCR assay","volume":"183","author":"Khansarinejad","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bjid.2020.04.015_bib0090","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jmv.23733","article-title":"Comparison of two quantitative real-time CMV-PCR tests calibrated against the 1st WHO international standard for viral load monitoring of renal transplant patients","volume":"85","author":"Mannonen","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0095","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/jmv.25189","article-title":"Transitioning cytomegalovirus viral load testing from a laboratory developed test to the cobas \u00ae CMV quantitative nucleic acid assay","volume":"90","author":"Payne","year":"2018","journal-title":"J Med Virol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/PDM.0b013e318033ab9e","article-title":"Analytic validation of a quantitative real-time PCR assay to measure CMV viral load in whole blood","volume":"16","author":"Thorne","year":"2007","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0105","unstructured":"Ho SY., Barry CP. Materials and method for detecting cytomegalovirus (CMV). US9085808B2. Available from: https:\/\/patents.google.com\/patent\/US9085808B2\/en [accessed 29.03.20]."},{"key":"10.1016\/j.bjid.2020.04.015_bib0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/v6020476","article-title":"Human cytomegalovirus UL34 early and late proteins are essential for viral replication","volume":"6","author":"Rana","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.bjid.2020.04.015_bib0115","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1128\/JVI.02697-07","article-title":"Nuclear localization sequences in cytomegalovirus capsid assembly proteins (UL80 Proteins) are required for virus production: inactivating NLS1, NLS2, or both affects replication to strikingly different extents","volume":"82","author":"Nguyen","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0120","first-page":"1","article-title":"Collaborative study to evaluate the proposed 1st WHO international standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays","author":"Fryer","year":"2010","journal-title":"Options"},{"key":"10.1016\/j.bjid.2020.04.015_bib0125","unstructured":"Banco Central do Brasil Cota\u00e7\u00f5es e boletins. Available from: https:\/\/www.bcb.gov.br\/estabilidadefinanceira\/historicocotacoes [accessed 05.03.20]."},{"key":"10.1016\/j.bjid.2020.04.015_bib0130","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/JCM.38.6.2122-2127.2000","article-title":"Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients","volume":"38","author":"Caliendo","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0135","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","article-title":"Application of viral-load kinetics to identify patients who develop cytomegalovirus","volume":"355","author":"Emery","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2020.04.015_bib0140","volume":"vol. 102","author":"Kotton","year":"2018"},{"key":"10.1016\/j.bjid.2020.04.015_bib0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1469-0691.2002.00449.x","article-title":"Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients","volume":"8","author":"Rollag","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2020.04.015_bib0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcv.2018.04.013","article-title":"Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results","volume":"104","author":"Naegele","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cid\/ciw370","article-title":"Are we there yet? Impact of the first international standard for cytomegalovirus DNA on the harmonization of results reported on plasma samples","volume":"63","author":"Preiksaitis","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2020.04.015_bib0160","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/jmv.22232","article-title":"Comparison of a UL111a real-time PCR and pp65 antigenemia for the detection of cytomegalovirus","volume":"83","author":"Beckmann","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0165","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/JCM.42.3.1142-1148.2004","article-title":"Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR","volume":"42","author":"Boeckh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0170","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/cid\/cis212","article-title":"Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective","volume":"54","author":"Kraft","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2020.04.015_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0160493","article-title":"Comparison of two commercial automated nucleic acid extraction and integrated quantitation real-time PCR platforms for the detection of cytomegalovirus in plasma","volume":"11","author":"Tsai","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bjid.2020.04.015_bib0180","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/JCM.01495-15","article-title":"Commutability of the first world health organization international standard for human cytomegalovirus","volume":"53","author":"Hayden","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0185","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/JCM.39.4.1334-1338.2001","article-title":"Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma","volume":"39","author":"Caliendo","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0190","first-page":"245","article-title":"Multicenter quality control study for human cytomegalovirus DNAemia quantification","volume":"32","author":"Lilleri","year":"2009","journal-title":"New Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0195","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3343\/alm.2016.36.6.603","article-title":"Performance evaluation of the Real-Q cytomegalovirus (CMV) quantification kit using two real-time PCR systems for quantifying CMV DNA in whole blood","volume":"36","author":"Park","year":"2016","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.bjid.2020.04.015_bib0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/ijmm.IJMM_18_126","article-title":"Performance of an in-house real-time PCR assay for detecting Cytomegalovirus infection among transplant patients from a tertiary care centre","volume":"36","author":"Duraisamy","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0205","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/JCM.03292-15","article-title":"Commutability of cytomegalovirus WHO international standard in different matrices","volume":"54","author":"Jones","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2020.04.015_bib0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/cis900","article-title":"An international multicenter performance analysis of cytomegalovirus load tests","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2020.04.015_bib0215","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/infdis\/jix069","article-title":"Determination of the biological form of human cytomegalovirus DNA in the plasma of solid-organ transplant recipients","volume":"215","author":"Tong","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjid.2020.04.015_bib0220","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1185\/030079908X280400","article-title":"A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial","volume":"24","author":"Lloyd","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bjid.2020.04.015_bib0225","first-page":"1279","article-title":"A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial","volume":"24","author":"Areda","year":"2011","journal-title":"Curr Med Res Opin"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867020300544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867020300544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:55:15Z","timestamp":1761407715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867020300544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1413867020300544"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2020.04.015","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost minimization analysis of an in-house molecular test for cytomegalovirus in relation to a commercial molecular system","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2020.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}